SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NEORX(nerx) -- Ignore unavailable to you. Want to Upgrade?

To: Mike K who wrote (554)12/7/1999 2:45:00 PM
From: Ron  Respond to of 661
 
7 Dec Company News NeoRx Corp. Said 12 of 27 patients tested in ongoing Phase II trial of its radiation therapy showed complete disappearance of myeloma cancer tumors. Patients had not responded to traditional chemotherapy, or suffered relapses after improving.
NeoRx expects a Phase III study to begin in 2000, along with pilot studies in prostate and breast cancer.



To: Mike K who wrote (554)12/7/1999 6:47:00 PM
From: OldAIMGuy  Read Replies (1) | Respond to of 661
 
Thanks Mike, Nice pop again today. And here we though we were going to have to bury the old dog!!

Best regards, Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News